Voglimore MF 500mg/0.2mg Tablet SR
Marketer
Morepen Laboratories Ltd
Salt Composition
Metformin (500mg) + Voglibose (0.2mg)
Overview Voglimore MF 500mg/0.2mg Tablet SR
Diabexe MF 500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, effectively regulating blood glucose levels. Diabexe MF should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Potential side effects, such as nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes, are typically transient and self-limiting. Persistent or concerning side effects warrant immediate medical attention. Your doctor can provide strategies for managing any adverse reactions. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal dysfunction. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals must consult their doctor before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.
Primary Ingredients of Voglimore MF 500mg/0.2mg Tablet SR
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Voglimore MF 500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Voglimore MF 500mg/0.2mg Tablet SR:
Consume Voglimore MF 500mg/0.2mg Tablet SR precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. This medication should be taken with a meal.
Common Side effects of Voglimore MF 500mg/0.2mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Voglimore MF 500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglimore MF 500mg/0.2mg Tablet SR whole; do not chew, crush, or divide the tablet. Administer with a meal.
How Voglimore MF 500mg/0.2mg Tablet SR works:
Voglimore MF 500mg/0.2mg extended-release tablets contain a dual-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglimore MF 500mg/0.2mg Tablet SR with alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Voglimore MF 500mg/0.2mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Voglimore MF 500mg/0.2mg tablets are likely not safe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Extended-release Voglimore MF 500mg/0.2mg tablets typically do not impair driving ability. Nevertheless, patients should be aware of the potential for low blood sugar (hypoglycemia) if taken concurrently with other diabetes medications like sulfonylureas, insulin, or repaglinide.
KidneyCAUTION
Patients with kidney impairment should use Voglimore MF 500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. Consult your physician for guidance. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Voglimore MF 500mg/0.2mg sustained-release tablets in individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Voglimore MF 500mg/0.2mg Tablet SR :
Should you forget a dose of Voglimore MF 500mg/0.2mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Voglimore MF 500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently